Diagnosis of Genital Tract Bioсenosis by Polymerase Chain Reaction in Women of Reproductive Age Using Separate Contraception Methods, With Thyroid Diseases
DOI:
https://doi.org/10.51699/ijhsms.v1i4.211Keywords:
contraceptives, urogenital system, vaginal microbiocenosis, dysbiosis, 16 packages of femoflor, Polymerase chain reaction (PCR) testAbstract
The target of the research is to study dynamically state the microbiocenosis of the genital tract in healthy and thyroid women using various contraceptives. Healthy women enable a normal vaginal microbiocenosis than women with thyroid disease. There is a necessity to take into account of negative influence of the different types of contraception on microbiota of genital system of women with thyroid disease in reproductive age. In this research the method of dynamics of urogenital tract microbiocenosis were investigated using the PCR technique. Consequently, the result showing substantially higher frequency of thyroid illness in healthy women than in women diagnosed with it characterizes the normal condition of vaginal microbiocenosis came out. In addition to the use of various contraceptives by women of reproductive age, the diagnosis of thyroid disease was taken into account of the negative impact on the microflora of the genital tract.
Downloads
References
Androsova, L., & Kontorshchikova, K. (2013). Characteristics of biocenoses of the urogenital tract in female reproductive age. Clinical Laboratory Diagnostics, 51-53.
Belyakina, I. (2013). Influence of various methods of contraception vaginal microbiocenosis and quality of life of women (pp. 21-23). Moscow.
Boldyreva, M., Lipova, E., & Alekseev, L. (2009). Characteristics of biogenic urogenital tract in female reproductive age by PCR method in real time. Journal Of Obstetrics And Women's Diseases, LVIII(6).
Vorontsova, A., & Zvychayny, M. (2011). The state of the vaginal biocenosis with the use of micronized progesterone. Obstetrics And Gynecology, 7-1, 70-72.
Voroshilina, E., Tumbinskaya, L., & Donnikov, A. (2010). Vaginal biocenosis in terms of quantitative PCR: state during pregnancy. Ural Medical Journal, 3(68), 103-107.
World Health Organization Regional Office for Europe. (2015). Medical eligibility criteria for the use of contraceptive methods 5th edition (pp. 44-45). Moscow.
National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I.Kulakov. (2011). Application of the polymerase chain reaction method in real time for assessing the microbiocenosis of the urogenital tract in women (Femoflor test) (medical technology) (p. 36). Moscow.
Mukhamedov, I., Khuzhaeva, S., Rizaev, Z., Almatov, B., & Nuraliev N.A., N. (2016). Clinic Microbiology (p. 632). Tashkent: "Yangi asr avlodi."
Donders G, Bellen G, Janssens D, Van Bulck B, Hinoul P, Verguts J. Influence of contraceptive choice on vaginal bacterial and fungal microflora // Eur J Clin Microbiol Infect Dis. – 2017. - N36(1). – P.43-48.
Drake R.W., Martins S.L., Whitaker A.K. Intrauterine device use in an urban university clinic: safety of use in a population at high risk for sexually transmitted infections // Contraception. – 2015. - N15. – P. 246-252.
Duijkers I, Klipping C, Heger-Mahn D, Fayad GN, Frenkl TL, Cruz SM, Korver T. Phase II dose-finding study on ovulation inhibition and cycle control associated with the use of contraceptive vaginal rings containing 17β-estradiol and the progestagens etonogestrel or nomegestrol acetate compared to NovaRing// Eur J Contracept Reprod Health Care. 2018. – Vol. 23(4). – P.245-254.
Eisenberg D.L., Schreiber C.A., Turok D.K., Teal S.B., Westhoff C.L., Creinin M.D.; ACCESS IUS Investigators. Three-year efficacy and safety of a new 52-mg levonorgestrel-releasing intrauterine system // Contraception. – 2015. - N1. - Р.10-16.
Espey E., Singh R.H., Leeman L., Ogburn T., Fowler K., Greene H. Misoprostol for intrauterine device insertion in nulliparous women: a randomized controlled trial // Am J Obstet Gynecol. – 2014. - N3. – Р.1-
Farajzadegan Z., Motamedi N., Nouri R., Kheyri M. Intrauterine device survival in Iranian women: systematic review and meta-analysis // J Family Med Prim Care. – 2015. - N2. – Р.203-207.
Fontenot H.B., Fantasia H.C. Long-Acting Reversible Contraception for Adolescents // NursWomens Health. – 2015. - N3. – Р.253-259.
Glass T.L. Infant feeding and contraceptive practices among adolescents with a high teen pregnancy rate: a 3-year // J Women’s Health (Latchet). - 2010. - N19(9). - P.1659-1663.
Gizzo S., Di Gangi S., Bertocco A., Noventa M., Fagherazzi S., Ancona E., Saccardi C., Patrelli T.S., D'Antona D., Nardelli G.B. Levonorgestrel intrauterine system in adjuvant tamoxifen treatment: balance of breast risks and endometrial benefits--systematic review of literature // Reprod Sci. - 2014.- N4. - Р.423-431.
Grentzer J.M., Peipert J.F., Zhao Q., McNicholas C., Secura G.M., Madden T. Risk-based Screening for Chlamydia trachomatis and Neisseria gonorrhea Prior to Intrauterine Device Insertion // Contraception. – 2015. - N15. - P.1-4.
Haidar J. Prevalence of anaemia, deficiencies of iron and folic acid and their determinants in Ethiopian women // J Health PopulNutr. – 2010. - Vol 28 N4. – Р.359-368.
Holton S., Rowe H., Kirkman M., Jordan L, McNamee K., Bayly C., McBain J., Sinnott V., Fisher J. Long-acting reversible contraception: Findings from the Understanding Fertility. Management in Contemporary Australia survey // Eur J ContraceptionRepro’d Health Care. - 2015. – N4. - Р.1-16.
Hamdamova M.T. The problem of the development of iron deficiency by using a copper-bearing intrauterine contraceptive // Europaische Fachho chschule. European Applied Sciences. – 2014. - N3. - P.44-45.
Ismail M.T., Fahmy D.M., Elshmaa N.S. Efficacy of levonorgestrel-releasing intrauterine system versus oral progestin’s in treatment of simple endometrial hyperplasia without atypia // Reprod Sci. – 2013. - N1. – Р.45-50.
Jahnavi G.Jahnavi Awareness regarding contraception and population control among school going adolescents // EastAfr J Public Health. – 2009. - Vol 6. - N3. – Р.226-228.
Johary J., Xue M., Zhu X., Xu D., Velu P.P. Efficacy of estrogen therapy in patients with intrauterine adhesions: systematic review // J Minim Invasive Gynecol. - 2014. - N1. - Р.44-54.
Kaislasuo J., Heikinheimo O., Lähteenmäki P., Suhonen S. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception // Hum Reprod. – 2015. - N7. - Р.1580-1588.
Kakaire O., Byamugisha J.K., Tumwesigye N.M., Gemzell-Danielsson K. Clinical versus laboratory screening for sexually transmitted infections prior to insertion of intrauterine contraception among women living with HIV/AIDS: a randomized controlled trial // Hum Reprod. – 2015. - N7. - Р.1573-1579.
Kaplanoglu M., Bülbül M., Yüce T., Kaplanoğlu D., Aban M. Mislocatedextrauterine intrauterine devices: Diagnosis and surgical management // J Turk GerGynecol Assoc. – 2015. - N2. – P.1-5.
Klein D.A., Arnold J.J., Reese E.S. Provision of Contraception: Key Recommendations from the CDC // Am Fam Physician. – 2015. - Vol. - N4. – Р.625-633.
